Summary of Pulmonary corticosteroids and mast cell inhibitors
Omalizumab (trade name Xolair) is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma.
Budesonide (trade name Pulmicort) is a steroid medication. It is available as an inhaler, pill, and nasal spray. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Flashcards on Pulmonary corticosteroids and mast cell inhibitors
Pulmonary corticosteroids and mast cell inhibitors
Which monoclonal antibody is used to treat asthma?